Company Monitoring Page for Gilead-Sciences

latest headlines for company on cafepharma

Drugmakers say Japan R&D spending at risk after government forces price cuts
Yahoo/Reuters
Fri, 04/1/16 - 09:25 am
Tags:
Japan, R&D, Gilead Sciences, Sovaldi
Biogen's Newer Problems; Their Relevance To The Biotech Sector
Seeking Alpha
Mon, 03/28/16 - 09:22 pm
Tags:
Biogen, Tecfidera, Merck, Ionis Pharmaceuticals, Gilead Sciences, Amgen, Regeneron
Gilead Sciences: ‘Another Pretender to Hepatitis C Throne Seems to Be Suffering the AbbVie Fate’
Barron's
Mon, 03/28/16 - 11:32 am
Tags:
Gilead Sciences, hepatitis C, Merck, Zepatier, Harvoni
Patent Payoff? Merck's and Ionis Pharmaceuticals' Take Could Be Tiny
Motley Fool
Sat, 03/26/16 - 01:04 pm
Tags:
Merck, Gilead Sciences, Ionis Pharmaceuticals, hepatitis C, patents, Harvoni, Sovaldi
Gilead to Pay Merck $200 Million in Damages Over Hepatitis C Drug Patents
WSJ Online
Fri, 03/25/16 - 09:42 am
Tags:
Gilead Sciences, Harvoni, Sovaldi, hepatitis C, Merck
Gilead has taken a lot of hits lately. Here’s what it really has to fear
Stat
Thu, 03/24/16 - 04:35 pm
Tags:
Gilead Sciences, hepatitis C, Harvoni, Sovaldi
Impact Of Merck Litigation On Ionis Pharmaceuticals
Seeking Alpha
Thu, 03/24/16 - 09:47 am
Tags:
Ionis Pharmaceuticals, Merck, Gilead Sciences, patents, hepatitis C
Gilead's CEO: We are appealing the case
CNBC
Wed, 03/23/16 - 09:45 pm
Tags:
Gilead Sciences, patents, Merck, John Milligan, Harvoni, Sovaldi, hepatitis C
Gilead, Biogen Troubles Remind Investors Why Strong Drug Patents Are Vital
TheStreet.com
Wed, 03/23/16 - 09:24 pm
Tags:
Gilead Sciences, Biogen, patents, Merck, Kyle Bass, Amgen, Regeneron, Sanofi
Gilead May Have to Pay Rival Merck Billions in Royalties
Fortune
Wed, 03/23/16 - 04:04 pm
Tags:
Gilead Sciences, Merck, patents, sofosbuvir, Harvoni, Sovaldi, hepatitis C
Merck wins major victory in hep C patent case against Gilead
BioPharma Dive
Wed, 03/23/16 - 09:45 am
Tags:
Merck, hepatitis C, patents, Gilead Sciences, sofosbuvir, Harvoni, Sovaldi
Gilead And The $3 Billion Merck Issue
Seeking Alpha
Fri, 03/18/16 - 11:10 am
Tags:
Gilead Sciences, Merck, patents, hepatitis C, Harvoni, Sovaldi
Gilead Cancer Business Loses Top Exec Prior to Study Halts
TheStreet.com
Thu, 03/17/16 - 09:48 am
Tags:
Gilead Sciences, clinical trials, Zydelig
As EMA investigates, Gilead halts six clinical trials of cancer drug
BioPharma Dive
Wed, 03/16/16 - 10:13 am
Tags:
Gilead Sciences, Europe, clinical trials, Zydelig
Gilead Cancer Drug Reviewed After Deaths in Combo Trials
Bloomberg
Mon, 03/14/16 - 10:10 am
Tags:
Gilead Sciences, clinical trials, Zydelig
VA to stop restricting hep C drugs, offering them to all infected veterans
Fierce Pharma
Sun, 03/13/16 - 01:13 pm
Tags:
Veterans Administration, hepatitis C, Gilead Sciences, AbbVie
Gilead (GILD) Stock Gains, Owns 94% of Hepatitis-C Market
TheStreet.com
Sat, 03/12/16 - 09:39 am
Tags:
Gilead Sciences, Harvoni, Sovaldi, hepatitis C
Inside the $100 million ad blitz for a $1,100-a-pill drug for hepatitis C
Stat
Wed, 03/9/16 - 10:31 am
Tags:
hepatitis C, drug ads, Harvoni, Gilead Sciences
Who Is Gilead Going To Buy?
Seeking Alpha
Mon, 03/7/16 - 10:07 pm
Tags:
Gilead Sciences, M&A, Genfit, Intercept Pharma, Agios Pharmaceuticals, Ziopharm
Gilead, Merck Spar Over Hepatitis C $1,000-Pill Royalties
Bloomberg
Mon, 03/7/16 - 09:58 pm
Tags:
Gilead Sciences, Merck, hepatitis C, Sovaldi, Harvoni

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.